HTLV I Associated Myelopathies: Clinical Trials

4 trials for HTLV I Associated Myelopathies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 1 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1
Phase 41Completed 1

Follow HTLV I Associated Myelopathies: new trials by email Literature Review of HTLV I Associated Myelopathies trials Research Report on HTLV I Associated Myelopathies

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection
Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection, Dolutegravir (DTG) - HTLV-1 Infection, HTLV I Associated Myelopathies
Phase 2RecruitingCarlos Brites1462026-05-072026-06-02
MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study
MP Diagnostics HTLV Blot 2.4 - HTLV-I Infections, HTLV-II Infections
Phase 4CompletedMP Biomedicals, LLC1502018-01-152018-09-13
Dual Algorithm Post Market Clinical Study
MP Diagnostics HTLV Blot 2.4 - HTLV-I Infections, HTLV-II Infections
CompletedMP Biomedicals, LLC1002017-03-012017-06-12
Evaluation of the MP Diagnostics HTLV Blot 2.4
CDPHL Algorithm - HTLV-I Infections, HTLV-II Infections
UnknownMP Biomedicals, LLC6002011-11-012011-11-08

Narrower conditions

HTLV-I Infections (4)  ·  Leukemia-Lymphoma, Adult T-Cell (4)  ·  Paraparesis, Tropical Spastic (4)  ·  HTLV-II Infections (3)  ·  Neuritis (1)

Broader conditions

Central Nervous System Diseases (4)  ·  Central Nervous System Infections (4)  ·  Deltaretrovirus Infections (4)  ·  Hematologic Diseases (4)  ·  Hemic and Lymphatic Diseases (4)  ·  Immune System Diseases (4)  ·  Immunologic Deficiency Syndromes (4)  ·  Immunoproliferative Disorders (4)  ·  Infections (4)  ·  Leukemia (4)  ·  Leukemia, Lymphoid (4)  ·  Leukemia, T-Cell (4)  ·  Lymphatic Diseases (4)  ·  Lymphoproliferative Disorders (4)  ·  Myelitis (4)

Interventions

Tenofovir (1)  ·  dolutegravir (1)

Sponsors

MP Biomedicals, LLC (3)  ·  Carlos Brites (1)

Countries

United States (3)  ·  Brazil (1)

Top investigators

Susan Stramer, Ph.D (2)  ·  Carlos Brites, MD, PhD (1)  ·  Sara Dionne, PhD (1)